0.34
0.34 (0%)
As of Aug 28, 2023
Mallinckrodt Plc [MNK]
Source:
Company Overview
Mallinckrodt plc is a global business of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies.
| Country | United States |
| Headquarters | dublin 15 |
| Phone Number | 353 1 6960000 |
| Industry | manufacturing |
| CEO | Sigurdur Olafsson |
| Website | mallinckrodt.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $243 |
| Operating Profit | $-20.2 |
| Net Income | $-38.2 |
| Net Cash | $70 |
Profit Ratios
| Gross Margin | $63.9 |
| Operating Margin | -8.3 |
| Profit as % of Revenues | -167.3% |
| Profit as % of Assets | -1.1% |
| Profit as % of Stockholder Equity | -2.3% |
Management Effectiveness
| Return on Equity | -2.3% |
| Return on Assets | -1.2% |
| Turnover Ratio | 6.9% |
| EBITA | $-20.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $3,302.6 |
| Total Liabilities | $1,656.8 |
| Operating Cash Flow | $178.4 |
| Investing Cash Flow | $-7.6 |
| Financing Cash Flow | $-102.2 |
